VIOXX litigation

Related by string. VIOXX Litigation * vioxx . Vioxx : withdrawn Vioxx painkiller . blockbuster painkiller Vioxx . withdrawn painkiller Vioxx . Vioxx Celebrex . popular painkiller Vioxx / litigations . LITIGATION . Litigations . Litigation : Securities Litigation Reform Act . Private Securities Litigation Reform . Litigation PIL filed . litigations involving . patent litigation * *

Related by context. Frequent words. (Click for all words.) 49 Oxandrin 48 IBNR 48 incentive accruals 48 LIFO inventory valuation 47 leasehold acquisitions 47 liquidating distributions 46 OLEPTRO TM 45 issue preclusion 45 doubtful accounts receivable 45 indemnifications 44 accounts receivable balances 44 obj obj = 44 FHCF 44 unfavorable variance 44 reexamination proceedings 44 Non GAAP adjusted EBITDA 43 LIFO inventory 43 mootness 43 litigation 43 postretirement benefit 43 #.#/BOE [002] 43 PLAVIX R 43 Neuftec 43 preclusive effect 43 factual determinations 43 reinstatement premiums 42 reargument 42 ridaforolimus 42 uncollectible accounts receivable 42 Petrowest 42 reviewed de novo 42 Cheniere Partners 42 Revolving Facility 42 theCompany 42 credit carryforwards 42 valuation allowances 42 accrual 42 avoid prejudicing 41 inventory obsolescence 41 patent infringement litigation 41 accruals 41 Chemicals Segment 41 revolver borrowings 41 Diavik Mine 41 Sandstorm Resources 41 Incurred 41 VNUS 41 reexaminations 41 pension curtailment 41 § #.# subd [005] 41 OTTI charge 41 arbitrability 41 indemnification 41 OPTi 41 Hi Shear 41 subsection b 40 unallocated expenses 40 intangible impairment 40 loss carryforward 40 Xantic 40 condensed consolidated 40 factual sufficiency 40 FCPA compliance 40 VIOXX 40 hedge ineffectiveness 40 Dedicated FN channel 40 CPIF 40 d Represents 40 reinsurance recoverables 40 Applera 40 patent litigation 40 unrealized hedging 40 applied prospectively 40 tables summarize 40 non recurring 40 Non Controlling Interest 40 reimbursable expenses 40 indemnification obligations 40 normalized FFO 40 OC BVI 40 exchangeable debentures 40 accretion expense 40 GSI Commerce expressly disclaims 40 AVRS 40 compensation accruals 39 Eligard R 39 CCAA proceedings 39 goodwill impairments 39 AnGes 39 TOCOSOL Paclitaxel 39 Evid. Code § 39 RC #.# B [002] 39 Tulsequah Project 39 recognized ratably 39 ERISA § 39 summary judgment motions 39 LightLab 39 outlicensing 39 People v. Wende 39 temporary impairment OTTI 39 FEHA

Back to home page